Federated Hermes, Inc. Lumos Pharma, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$11.58 - $31.11 $3,867 - $10,390	-334 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$13.61 - $35.91 $1,646 - $4,345	-121 Reduced 26.59%	334 $12,000
Q3 2020 Nov 12, 2020	BUY	$13.25 - $16.5 $4,531 - $5,643	342 Added 302.65%	455 $6,000
Q2 2020 Aug 13, 2020	BUY	$7.76 - $16.99 $85 - $186	11 Added 10.78%	113 $2,000
Q1 2020 May 13, 2020	BUY	$0.89 - $8.85 $90 - $902	102 New	102 $1,000

2.2M

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.